Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia
Heng, G; Jia, JK; Li, SQ; Fu, G; Wang, ML; Qin, DB; Li, YY; Pei, L; Tian, XB; Zhang, JS; Wu, Y; Xiang, SL; Wan, J; Zhu, W; Zhang, P; Zhang, QZ; Peng, X; Wang, LL; Wang, P; Wei, ZH; Zhang, YZ; Wang, GQ; Chen, X; Zhang, CC; Sun, YN; Zhao, WX; Fan, YH; Yang, Z; Chen, JP; Qian, C
Yang, Z (corresponding author), Army Med Univ, Ctr Biol Therapy, Southwest Hosp, Third Mil Med Univ, Chongqing, Peoples R China.; Chen, JP (corresponding author), Army Med Univ, Ctr Haematol, Southwest Hosp, Third Mil Med Univ, Chongqing, Peoples R China.; Qian, C (corresponding author), Army Med Univ, Southwest Hosp, Third Mil Med Univ, Gaotanyan 30, Chongqing 400038, Peoples R China.
CLINICAL CANCER RESEARCH, 2020; 26 (7): 1606
